Noteworthy - Pharmaceutical Executive



Clearing the Emerging Market Hurdles

November 18, 2013

Despite the long-held promise of the emerging markets, dominance in these territories has eluded Big Pharma. Hussain Mooraj addresses the key issues and offers a strategy for success.

Get Real: Preparing for the Real World Evidence Future

November 12, 2013

Why Real World Evidence (RWE) is here to stay, and what you need to do to integrate it into your business strategy as painlessly as possible.

Brazil Improves Access to Experimental Drugs

November 11, 2013

New regulation offers drug options for patients with rare, severe, or debilitating illnesses.

Defying Gravity at the Patent Cliff

November 2, 2013

Pharmaceutical companies are using formulation strategies as a lifecycle management tool to maximize product value and preserve their revenue streams.

Top Medical Innovations for 2014

November 1, 2013

At the conclusion of the Cleveland Clinic's Medical Innovations Summit each year, 10 innovative technologies are unveiled before the audience, and designated as new and revolutionary tools for the treatment of disease and disability.

2014 Pipeline Report: The Sprint to Value

November 1, 2013

Across a constellation of categories, bright new drugs are moving into position. The pharma model may have changed, but companies are keeping their blockbusters.

Supply Chain: Scanning the Future

November 1, 2013

The US and Europe are moving toward the enactment of new legislation that will change the way pharma products are handled and shipped throughout the supply chain.

Big Pharma's Newest Cost Center

October 31, 2013

As the burden of promotional disclosure expands beyond US shores, understanding the rules and then controlling the cost of compliance is a strategic necessity.

In the Digital Age, Don't Forget to G.O.Y.A

October 22, 2013

Digital devices have made it possible to conduct business without ever leaving your desk. But something is just plain old wrong with that, writes Al Topin.


Click here